ArticleCell death and differentiation2019

PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.

Carole Beck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.